t e c h n i c a l r e p o r t s Approximately 100,000 individuals in the United States currently await kidney transplantation, and 400,000 individuals live with end-stage kidney disease requiring hemodialysis. The creation of a transplantable graft to permanently replace kidney function would address donor organ shortage and the morbidity associated with immunosuppression. Such a bioengineered graft must have the kidney's architecture and function and permit perfusion, filtration, secretion, absorption and drainage of urine. We decellularized rat, porcine and human kidneys by detergent perfusion, yielding acellular scaffolds with vascular, cortical and medullary architecture, a collecting system and ureters. To regenerate functional tissue, we seeded rat kidney scaffolds with epithelial and endothelial cells and perfused these cellseeded constructs in a whole-organ bioreactor. The resulting grafts produced rudimentary urine in vitro when perfused through their intrinsic vascular bed. When transplanted in an orthotopic position in rat, the grafts were perfused by the recipient's circulation and produced urine through the ureteral conduit in vivo.
Nearly 1 million patients in the United States live with end-stage renal disease (ESRD), with over 100,000 new diagnoses every year 1 . Although hemodialysis has increased the survival of patients with ESRD, transplantation remains the only available curative treatment. About 18,000 kidney transplants are performed per year in the United States 1 , yet approximately 100,000 Americans currently await a donor kidney 2 . Stagnant donor organ numbers have increased waiting times to over 3 years and waitlist mortality to 5-10%. Despite advances in renal transplant immunology 3 , 20% of recipients will experience an episode of acute rejection within 5 years of transplantation, and approximately 40% of recipients will die or lose graft function within 10 years after transplantation. Creation of a bioengineered kidney could theoretically bypass these problems by providing an autologous graft on demand.
Hemofiltration and hemodialysis use an acellular semipermeable membrane to substitute the native kidney's functions. Several attempts have been made to bioengineer viable tubular structures to further supplement hemofiltration with cell-dependent functions 4, 5 . When hemofiltration devices have been combined with bioengineered renal tubules, the resulting bioartificial kidney replaced renal function in uremic dogs 6 and temporarily improved renal function in patients with acute renal failure 7, 8 . In an alternative approach, kidney primordia have been shown to develop into functional organs in vivo and prolong life when transplanted into anephric rats 9 . Devices to make renal-assist devices more portable 10 or even implantable 11 have reached the stage of preclinical evaluation and hold tremendous promise for improving the quality of life of patients in end-stage renal failure. Autologous urinary tract tissue generated from biocompatible matrix and patient-derived cells has been used clinically for bladder augmentation 12 . A key step toward a fully implantable, permanent graft is the development of a biocompatible scaffold that facilitates cell engraftment and function and allows full recipient integration through blood perfusion.
On the basis of our previous experience with whole-organ heart 13 and lung 14 extracellular matrix (ECM) scaffolds, we hypothesized that the native kidney ECM could provide such a scaffold for subsequent cell seeding. In previous studies, detergents were used to remove cells from native kidney ECM while preserving the biomechanical properties and matrix protein characteristics in tissue slices 15 and whole organs [16] [17] [18] [19] . We therefore decellularized kidneys using detergent perfusion to create whole-organ scaffolds with intact and perfusable vascular, glomerular and tubular compartments. We repopulated the decellularized kidney scaffolds with endothelial and epithelial cells. In vitro biomimetic culture using arterial perfusion led to the formation of functional renal grafts. To test in vivo host integration and function, we transplanted bioengineered kidneys in an orthotopic position and documented urine production.
RESULTS

Perfusion decellularization of cadaveric kidneys
We decellularized cadaveric rat kidneys using renal artery perfusion with 1% sodium dodecyl sulfate (SDS) at a constant pressure of 40 mm Hg (Fig. 1a) . Histology of the acellular kidneys showed preservation of tissue architecture and the complete removal of nuclei and cellular components ( Fig. 1b) . Perfusion decellularization preserved the structure and composition of the renal ECM, which is integral in filtration (glomerular basement membrane), secretion and reabsorption (tubular basement membrane). As has been seen with other tissues 13, 14 , the arterial elastic fiber network remained preserved in acellular cortical and medullary parenchyma. Immunohistochemical staining confirmed the presence of key ECM components such as laminin and collagen IV in a physiologic distribution, for example, in the acellular glomerular basement membrane ( Fig. 1c,d) . The microarchitecture of the lobulated glomerular basement membrane with the capillary and mesangial matrix extending from the centrilobular stalk remained intact. Acellular glomeruli were further encompassed by a multilayered corrugated and continuous Bowman's capsule basement membrane ( Fig. 1e,f) . Tubular basement membranes remained preserved, with dentate evaginations extending into the proximal tubular lumen. SDS, deionized water and Triton X-100 reduced the total DNA content per kidney to less than 10% ( Fig. 1g ). After washing with PBS, SDS was undetectable in the acellular kidney scaffolds. Concentrations of total collagen and glycosaminoglycans in the ECM were preserved at levels not significantly different from those in cadaveric kidney tissue ( Fig. 1h) . To confirm the scalability of the perfusion decellularization protocol to kidneys of large animals and humans, we successfully decellularized porcine and human kidneys using a similar perfusion protocol ( Fig. 2a-d) . We confirmed preservation of perfusable channels along a hierarchical vascular bed by dye perfusion in a manner similar to that in our previous experiments with perfusion of decellularized hearts and lungs 13, 14 (Supplementary  Fig. 1 ). Functional testing of acellular kidney scaffolds by perfusion of the vasculature with modified Krebs-Henseleit solution under physiologic perfusion pressure resulted in production of a filtrate that was high in protein, glucose and electrolytes, suggesting hydrostatic filtration across glomerular and tubular basement membranes with loss of macromolecular sieving and active reabsorption.
To assess the microarchitecture of the acellular kidney scaffolds, we applied an established histology-based morphometry protocol to quantify the average number of glomeruli, glomerular diameter, glomerular capillary lumen and partial Bowman's space 20 . The total number of glomeruli remained unchanged between cadaveric and decellularized kidney cross sections through the hilum (12,380.25 ± 967.37 (mean ± s.d.) compared to 14,790.35 ± 2,504.93, respectively; P = 0.931). Glomerular diameter, Bowman's space and glomerular capillary surface area did not differ between cadaveric and decellularized kidneys (Supplementary Table 1 ).
Recellularization of acellular kidney scaffolds
To regenerate functional kidney tissue, we repopulated acellular rat kidneys with endothelial and epithelial cells. We instilled suspended human umbilical venous endothelial cells (HUVECs) through the renal artery and suspended rat neonatal kidney cells (NKCs) through the ureter. Cell delivery and retention improved when kidney scaffolds were mounted in a seeding chamber under a vacuum to generate a pressure gradient across the scaffold (Fig. 3a) . Attempts to seed NKCs by applying positive pressure to the collecting system did not reach the glomerulus, whereas cell seeding using a transrenal gradient allowed for cell dispersion throughout the entire kidney parenchyma. Vacuum pressure exceeding 70 cm H 2 O led to tissue damage in the calyxes and parenchyma, but a vacuum pressure of 40 cm H 2 O did not cause macroscopic or microscopic tissue damage or leakage of cells, which is consistent with data on isolated tubular basement membrane mechanical properties 21 . After seeding, we transferred kidney constructs to a perfusion bioreactor designed to provide whole-organ npg t e c h n i c a l r e p o r t s culture conditions (Fig. 3b,c) . After 3-5 d of perfused organ culture, HUVECs lined the vascular channels throughout the entire scaffold cross section from segmental, interlobar and arcuate arteries to glomerular and peritubular capillaries ( Fig. 3d) .
Because a variety of epithelial cell phenotypes in different niches along the nephron contribute to urine production, we elected to reseed a combination of rat NKCs through the ureter in addition to HUVECs through the renal artery. Freshly isolated, enzymatic digests of rat neonatal kidneys produced single-cell suspensions of NKCs consisting of a heterogeneous mixture of all kidney cell types, most of which were of epithelial lineage but some of which were of endothelial and interstitial lineages. When cultured on cell-culture plastic after isolation, 8% of adherent cells expressed podocin, indicating a glomerular epithelial phenotype, 69% expressed Na/K-ATPase, indicating a proximal tubular phenotype, and 25% expressed E-cadherin, indicating a distal tubular phenotype (data not shown). After cell seeding, we mounted the kidney constructs in a perfusion bioreactor and cultured them in whole-organ biomimetic culture. An initial period of static culture enabled cell attachment, after which we initiated perfusion to provide oxygenation, nutrient supply and a filtration stimulus.
Neonatal rats are unable to excrete concentrated urine due to immaturity of the tubular apparatus 22 . To accelerate in vitro nephrogenesis and maturation of NKCs in acellular kidney matrices, we supplemented the culture medium with in vivo maturation signals such as glucocorticoids and catecholamines. We cultured the reseeded kidneys under physiologic conditions for up to 12 d. By histologic evaluation after as early as 4 d in culture, we found repopulation of the renal scaffold with epithelial and endothelial cells and preservation of glomerular, tubular and vascular architecture. NKCs and HUVECs engrafted in their appropriate epithelial and vascular compartments (Fig. 3e) . The spatial relationship of the regenerated epithelium and endothelium resembled the microanatomy and polarity of the native nephron, providing the anatomic basis for water and solute filtration, secretion and reabsorption. Immunostaining revealed densely seeded glomeruli with endothelial cells and podocytes. Across the entire kidney, podocytes seemed to preferentially engraft in glomerular regions, although we did find occasional non-site specific engraftment ( Fig. 3f,g) . Epithelial cells on the glomerular basement membranes stained positive for β-1 integrin, suggesting site-specific cell adhesion to ECM domains ( Fig. 3h) . We found that engrafted epithelial cells reestablished polarity and organized in tubular structures expressing Na/K-ATPase and aquaporin, which is similar to native proximal tubular epithelium. Epithelial cells expressing E-cadherin formed structures resembling native distal tubular epithelium and collecting ducts ( Fig. 3e,h) . E-cadherin-positive epithelial cells lined the renal pelvis, which is similar to native transitional epithelium. Transmission and scanning electron microscopy of regenerated kidneys showed perfused glomerular capillaries with engrafted podocytes and formation of foot processes (Fig. 3i,j) . Morphometric analysis of regenerated kidneys showed recellularization of more than half of the glomerular matrices, resulting in an average number of cellular glomeruli per regenerated kidney that was approximately 70% that of cadaveric kidneys. The average glomerular diameter, Bowman's space and glomerular capillary lumen were smaller in regenerated kidneys compared to cadaveric kidneys (Supplementary Table 2 ).
In vitro function of acellular and regenerated kidneys
After cell seeding and whole-organ culture, we tested the in vitro capacity of regenerated kidneys to filter a standardized perfusate, clear metabolites, reabsorb electrolytes and glucose and generate concentrated urine (Fig. 4a) . Decellularized kidneys produced nearly twice as much filtrate as cadaveric controls, and regenerated kidneys produced the least amount of urine. All three groups maintained a steady urine output over the testing period ( Fig. 4b) . On the basis of the results of urinalysis, we calculated creatinine clearance as an estimate for glomerular filtration rate and fractional solute excretion as a measure of tubular absorptive and secretory function ( Fig. 4c) . Because of increased dilute urine production, the calculated creatinine clearance was increased in decellularized kidneys when compared to cadaveric kidneys, indicating increased glomerular (and probably additional tubular and ductal) filtration across acellular basement membranes. After repopulation with endothelial and epithelial cells, creatinine clearance of regenerated constructs reached approximately 10% of that in cadaveric kidneys, which indicates a decrease of glomerular filtration across a partially reconstituted and probably immature glomerular membrane ( Fig. 4c) .
We found that vascular resistance increased with decellularization and decreased after re-endothelialization, but it remained higher in regenerated constructs compared to cadaveric kidneys (Fig. 4d) . This finding is in line with previous observations in cardiac and pulmonary re-endothelialization 13, 14 and may be related to the relative immaturity of the vascular bed and microemboli from cell-culture medium. When we increased the in vitro renal arterial perfusion pressure to 120 mm Hg, urine production and creatinine clearance in regenerated kidneys reached up to 23% of that in cadaveric kidneys ( Fig. 4b,c) . Albumin retention was decreased from 89.9% in cadaveric kidneys to 23.3% in decellularized kidneys, which is an amount consistent with the estimated contribution of the denuded glomerular basement membrane to macromolecular sieving. With recellularization, albumin retention was partially restored to 46.9%, leading to improved albuminuria in regenerated kidneys. Glucose reabsorption decreased from 91.7% in cadaveric kidneys to 2.8% after npg decellularization, consistent with free filtration and the loss of tubular epithelium. Regenerated kidneys showed partially restored glucose reabsorption of 47.38%, suggesting engraftment of proximal tubular epithelial cells with functional membrane transporters, resulting in decreased glucosuria. Higher perfusion pressure did not lead to increased albumin or glucose loss in regenerated kidneys. Selective electrolyte reabsorption was lost in decellularized kidneys. Slightly more creatinine than electrolytes were filtered, leading to an effective fractional electrolyte retention ranging from 5% to 10%. This difference may be attributed to the electrical charge of the retained ions and the basement membrane 23 , whereas the range among ions may be related to subtle differences in diffusion dynamics across acellular vascular, glomerular and tubular basement membranes. In regenerated kidneys, electrolyte reabsorption was restored to approximately 50% of physiologic levels, which further indicates engraftment and function of proximal and distal tubular epithelial cells. Fractional urea excretion was increased in decellularized kidneys and returned to a more physiologic range in regenerated kidneys, which suggests partial reconstitution of functional collecting duct epithelium with urea transporters. For further details about the urinalysis and fractional excretion, see Supplementary Table 3 .
Orthotopic transplantation of regenerated kidneys
Because we observed urine production in vitro, we hypothesized that regenerated kidneys could function in vivo after orthotopic transplantation. We performed experimental left nephrectomies We anastomosed regenerated left kidneys to the recipient's renal artery and vein (Fig. 4e) . Throughout the entire test period, regenerated kidney grafts seemed well perfused without any evidence of bleeding from the vasculature, collecting system or parenchyma (Fig. 4e) .
The ureter remained cannulated to document in vivo production of clear urine without evidence of gross hematuria and to collect urine samples. Regenerated kidneys produced urine from shortly after the unclamping of recipient vasculature until the planned termination of the experiment. Histological evaluation of explanted regenerated kidneys showed blood-perfused vasculature without evidence of parenchymal bleeding or microvascular thrombus formation (Fig. 4f) .
Corresponding to the in vitro studies, decellularized kidneys produced a filtrate that was high in glucose (249 ± 62.9 mg dl −1 (mean ± s.d.) compared to 29 ± 8.5 mg dl −1 in native controls) and albumin (26.85 ± 4.03 g dl −1 compared to 0.6 ± 0.4 g dl −1 in controls) but low in urea (18 ± 42.2 mg dl −1 compared to 617.3 ± 34.8 mg dl −1 in controls) and creatinine (0.5 ± 0.3 mg dl −1 compared to 24.6 ± 5.8 mg dl −1 in controls). Regenerated kidneys produced less urine than native kidneys (1.2 ± 0.1 µl min −1 (mean ± s.d.) compared to 3.2 ± 0.9 µl min −1 in native controls and 4.9 ± 1.4 µl min −1 in decellularized kidneys) with lower creatinine (1.3 ± 0.2 mg dl −1 ) and urea (28.3 ± 8.5 mg dl −1 ) than native controls but showed improved glucosuria (160 ± 20 mg dl −1 ) and albuminuria (4.67 ± 2.51 g l −1 ) when compared to decellularized kidneys. Also consistent with the in vitro results, creatinine clearance in regenerated kidneys was lower than that in native kidneys (0.01 ± 0.002 ml min −1 compared to 0.36 ± 0.09 ml min −1 in controls), as was urea excretion (0.003 ± 0.001 mg min −1 compared to 0.19 ± 0.01 mg min −1 in controls). Orthotopic transplantation of regenerated kidneys showed immediate graft function during blood perfusion through the recipient's vasculature in vivo without signs of clot formation or bleeding. Results of urinalysis corresponded to the in vitro observation of the relative immaturity of the constructs.
DISCUSSION
A bioengineered kidney derived from patient-derived cells and regenerated 'on demand' for transplantation could provide an alternative treatment for patients suffering from renal failure. Although many hurdles remain, we describe a new approach for the creation of such a graft and report three milestones: the generation of three-dimensional acellular renal scaffolds using perfusion decellularization of cadaveric rat, porcine and human kidneys; the repopulation of endothelial and epithelial compartments of such renal scaffolds, leading to the formation of viable tissue; and excretory function of the resulting graft during perfusion through its vasculature in vitro and after orthotopic transplantation in vivo.
In line with previous studies, we confirmed that detergent decellularization of whole rat, porcine and human kidneys removes cells and cellular debris without disruption of vascular, glomerular and tubular ultrastructure 14, [16] [17] [18] . Decellularization led to a loss of cellmediated functions such as macromolecular sieving and solute transport. Glomerular and tubular basement membranes are permeable to macromolecules, small solutes and water because filtration and reabsorption occur across these barriers in the native kidney 21, 24 . Because macromolecule retention, secretion and reabsorption of metabolites and electrolytes and regulation of an acid-base equilibrium depend on viable endothelium and epithelium, we repopulated acellular scaffolds with endothelial and immature epithelial cells 25 . Whereas cell seeding of tissues such as muscle, vasculature or trachea can be accomplished by surface attachment or intraparenchymal injection, repopulation of a more complex organ such as the kidney poses numerous challenges 26, 27 . Similarly to in our previous experiments with lungs, we took advantage of pre-existing vascular and urinary compartments and seeded endothelial cells through the vascular tree and epithelial cells through the collecting system 13 . The length and diameter of the acellular nephrons posed a major challenge to cell seeding from the urinary side. Tubule elasticity and permeability increase with decellularization, whereas tubular diameters increase with pressure 21 . Here a transrenal pressure gradient during the initial cell seeding substantially increased cell delivery and retention. Glomerular ECM structures predominantly repopulated with podocytes, whereas tubular structures repopulated with tubular epithelial cells with reestablished polarity. Such site-selective engraftment of podocytes on glomerular basement membranes highlights the value of native ECM in tissue regeneration. Laminins and collagen IV are the major ECM proteins of the glomerular basement membrane and are necessary for podocyte adhesion, slit diaphragm formation and glomerular barrier function 28, 29 . Immunohistochemical staining of matrix cross npg sections in our study showed preservation of these proteins within the glomerular basement membrane after perfusion decellularization.
In vitro, α3β1 integrin mediates rat podocyte adhesion and regulates anchorage-dependent growth and cell-cycle control 30, 31 . Preserved glomerular basement membrane proteins in decellularized kidney scaffolds and β-1 integrin expression in engrafted podocytes suggest site-specific cell adhesion to physiologic ECM domains. After several days in organ culture, regenerated kidney constructs produced urine in vitro. The intact whole-organ architecture of regenerated kidneys provided a unique opportunity for global functional testing and assessment of in vivo function after transplantation. In regenerated kidneys, macromolecular sieving, glucose and electrolyte reabsorption were partially restored, indicating engraftment and function of endothelial cells, podocytes and tubular epithelial cells. The glomerular filtration rate in regenerated kidneys was lower compared to in cadaveric kidneys, which was in part a result of increased vascular resistance leading to decreased graft perfusion. Creatinine clearance improved with increased renal arterial perfusion pressures. Fractional reabsorption of electrolytes did not reach the levels of cadaveric kidneys, which could be related to incomplete seeding and the immature stage of seeded neonatal epithelial cells 22 . Further maturation of the cell-seeded constructs will probably improve vascular patency and control of electrolyte reabsorption 28 . Despite this functional immaturity, regenerated kidney constructs provided urine production and clearance of metabolites after transplantation in vivo. We did not observe bleeding or graft thrombosis during perfusion through the recipient's vascular system. Successful orthotopic transplantation in rats demonstrates the advantage of physiologic graft size and anatomic features such as renal vascular conduits and ureter. Once developed further, bioengineered kidneys could become a fully implantable treatment option for renal support in end-stage kidney disease.
In summary, cadaveric kidneys can be decellularized, repopulated with endothelial and epithelial cells, matured to functional kidney constructs in vitro and transplanted in an orthotopic position to provide excretory function in vivo. Translation of this technology beyond proof of principle will require the optimization of cell-seeding protocols to human-sized scaffolds and an upscaling of biomimetic organ culture, as well as the isolation, differentiation and expansion of the required cell types from clinically feasible sources.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
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AUtHOR COntRIBUtIOnS
ONLINE METhODS
Perfusion decellularization of kidneys. We isolated 68 rat kidneys for perfusion decellularization. All animal experiments were performed in accordance with the Animal Welfare Act and approved by the institutional animal care and use committee at Massachusetts General Hospital. We anesthetized male, 12-week-old Sprague-Dawley rats (Charles River Labs) using inhaled 5% isoflurane (Baxter). After systemic heparinization (American Pharmaceutical Partners) through the infrahepatic inferior vena cava, a median laparotomy exposed the retroperitoneum. After removal of the Gerota's fascia, perirenal fat and kidney capsule, we transected the renal artery, vein and ureter and retrieved the kidney from the abdomen. We cannulated the ureter with a 25-gauge cannula (Harvard Apparatus). Then we cannulated the renal artery with a prefilled 25-guage cannula (Harvard Apparatus) to allow antegrade arterial perfusion of heparinized PBS (Invitrogen) at 30 mm Hg arterial pressure for 15 min to rid the kidney of residual blood. We then administered decellularization solutions at 30 mm Hg of constant pressure in the following order: 12 h of 1% SDS (Fisher) in deionized water, 15 min of deionized water and 30 min of 1% Triton X-100 (Sigma) in deionized water. After decellularization, we washed the kidney scaffolds with PBS containing 10,000 U/ml penicillin G, 10 mg/ml streptomycin and 25 µg/ml amphotericin B (Sigma) at 1.5 ml per min constant arterial perfusion for 96 h.
Rat neonatal kidney cell isolation. We euthanized day 2.5-3.0 Sprague-Dawley neonates for organ harvests. We then excised both kidneys by median laparotomy and stored them on ice (4 °C) in renal epithelial growth medium (REGM, Lonza). We transferred kidneys to a 100-mm culture dish (Corning) for residual connective tissue removal and subsequent mincing into <1 mm 3 pieces. The renal tissue slurry was resuspended in 1 mg/ml collagenase I (Invitrogen) and 1 mg/ml dispase (StemCell Technologies) in DMEM (Invitrogen) and incubated in a 37 °C shaker for 30 min. The resulting digest slurry was strained (100 µm; Fisher) and washed with 4 °C REGM. We then resuspended nonstrained tissue digested in collagenase and dispase as described above and repeated the incubation, straining and blocking. The resulting cell solution was centrifuged (200g, 5 min), and cell pellets were resuspended in 2.5 ml REGM, counted and seeded into acellular kidney scaffolds as described below.
HUVEC subculture and preparation. We expanded mCherry-labeled HUVECs at passages 8-10 on gelatin A-coated (BD Biosciences) cell-culture plastic and grew the cells with endothelial growth medium-2 (EGM2, Lonza). At the time of seeding, cells were trypsinized, centrifuged, resuspended in 2.0 ml of EGM2, counted and subsequently seeded into decellularized kidneys as described below.
Cell seeding. We trypsinized and diluted 50.67 × 10 6 ± 12.84 × 10 6 (mean ± s.d.) HUVECs in 2.0 ml EGM2 and seeded these onto the acellular kidney scaffold through the arterial cannula at a constant flow of 1.0 ml per min. Cells were allowed to attach overnight, after which perfusion culture resumed. Following the procedure above, 60.71 × 10 6 ± 11.67 × 10 6 rat neonatal kidney cells were isolated, counted and resuspended in 2.5 ml of REGM. The cell suspension was seeded through the ureter cannula after subjecting the organ chamber to a −40 cm H 2 O pressure. Cells were allowed to attach overnight, after which perfusion culture resumed.
Bioreactor design and whole-organ culture. We designed and custom built the kidney bioreactor as a closed system that could be gas sterilized after cleaning and assembly, needing only to be opened once at the time of organ placement. Perfusion media and cell suspensions were infused through sterile access ports (Cole-Parmer) to minimize the risk of contamination. Media was allowed to equilibrate with 5% CO 2 and 95% room air by flowing through a silicone tube oxygenator (Cole-Parmer) before reaching the cannulated renal artery at 1.5 ml per min. The ureter and vein were allowed to drain passively into the reservoir during the biomimetic culture.
Isolated kidney experiments.
To assess in vitro kidney function, we perfused single native, regenerated and decellularized kidneys with 0.22 µm-filtered (Fisher) Krebs-Henseleit solution containing NaHCO 3 (25.0 mM), NaCl (118 mM), KCl (4.7 mM), MgSO 4 (1.2 mM), NaH 2 PO 4 (1.2 mM), CaCl 2 (1.2 mM), BSA (5.0 g/dl), d-glucose (100 mg/dl), urea (12 mg/dl) and creatinine (20 mg/dl), (Sigma-Aldrich). We added the amino acids glycine (750 mg/l), l-alanine (890 mg/l), l-asparagine (1,320 mg/l), l-aspartic acid (1,330 mg/l), l-glutamic acid (1,470 mg/l), l-proline (1,150 mg/l) and l-serine (1,050 mg/l) before testing (Invitrogen). Krebs-Henseleit solution was oxygenated (5% CO 2 and 95% O 2 ), warmed (37 °C) and perfused through the arterial cannula at constant pressures of 80-120 mm Hg without recirculation. Urine and venous effluent passively drained into separate collection tubes. We took samples at 10, 20, 30, 40 and 50 min after initiating perfusion and froze them immediately at -80 °C until analysis. Urine, venous effluent and perfusing Krebs-Henseleit solutions were quantified using a Catalyst Dx Chemistry Analyzer (IDEXX). We calculated the vascular resistance (RVR) as arterial pressure (mm Hg)/renal blood flow (ml/g/min). After completion of in vitro experiments, we flushed kidneys with sterile PBS, decannulated them and transferred to a sterile container in cold (4 °C) PBS until further processing.
Histology, immunofluorescence and immunohistochemistry. We processed native, decellularized and regenerated kidneys following the identical fixation protocol for paraffin embedding (5% formalin buffered PBS; Fisher) for 24 h at room temperature, and the sections to be frozen were fixed overnight in 4% paraformaldehyde (Fisher) at 4 °C. We embedded sections in paraffin or Tissue Tek Optimal Cutting Temperature (OCT) compound (VWR) for sectioning following standard protocols. Tissue sections were cut into 5-µm sections, and H&E staining was performed (Sigma-Aldrich) using standard protocols. Sections were also stained with Movat's pentachrome (American Mastertech) following the manufacturer's protocol.
Paraffin-embedded sections underwent deparaffinization with two changes of xylene (5 min), two changes of 100% ethanol (3 min) and two changes of 95% ethanol (3 min) and were placed in deionized water (solutions all from Fisher). For immunostaining, deparaffinized slides first underwent antigen retrieval in heated (95 °C) sodium citrate buffer solution, pH 6.0 (Dako), for 20 min and were then allowed to cool to room temperature for 20 min. For immunostaining of collagen IV, elastin and laminin epitopes, slides were blocked for 5 min in PBS and then incubated with 20 mg/ml Proteinase K (Sigma) in TE (Tris and EDTA) buffer, pH 8.0, at 37 °C for 10 min. After a 5-min block in PBS, slides received Dual Endogenous Enzyme-Blocking Reagent (Dako) for 5 min and then blocking buffer (1% BSA and 0.1% Triton X-100 in PBS; Sigma) for 30 min. Primary antibodies were allowed to attach overnight at 4 °C. Primary antibody dilutions were made with blocking buffer and were as follows: 1:50 antibody to elastin (Santa Cruz Biotechnology, sc-17581), 1:50 antibody to laminin Y-1 (B-4) (Santa Cruz Biotechnology, sc-13144), 1:50 antibody to collagen IV (Lifespan Bioscience, LS-C79592), 1:200 antibody to podocin (Abcam, ab50339), 1:200 antibody to Na/K-ATPase (Abcam, ab7671) and 1:200 antibody to E-cadherin (BD Biosciences, 610181). After primary antibody incubation, slides were washed in PBS for 5 min, and a secondary antibody conjugated to horseradish peroxidase (HRP) was added at 1:100 for 30 min (Dako). The resulting slides were washed with PBS and developed with 3,3′-diaminobenzidine (Dako) until good staining intensity was observed. Nuclei were counterstained with hematoxylin (Sigma). A coverslip was mounted using permount (Fisher) after dehydration with a sequential alcohol gradient and xylene (Fisher).
For immunofluorescence, paraffin-embedded sections underwent deparaffinization and antigen retrieval and received primary antibody dilutions prepared in blocking buffer as described above. After primary antibody addition, slides were blocked as described above. Fluorescent secondary antibodies, all 1:250 diluted in blocking buffer (anti-species conjugated to Alexa fluorophores; Invitrogen) were allowed to attach for 45 min. Nuclei were counterstained with DAPI (Invitrogen) and coverslip (Fisher) mounted using ProLong Gold antifade reagent (Invitrogen, P36930).
Omission of primary antibody and species immunoglobulin G1 antibody (Vector Labs) served as negative controls for both immunohistochemistry and immunofluorescence. Immunohistochemistry, H&E-and pentachromestained images were recorded using a Nikon Eclipse TE200 microscope (Nikon), and immunofluorescent images were recorded using a Nikon A1R-A1 confocal microscope (Nikon). In the version of this article initially published, the human kidneys in Figure 2a ,b were incorrectly described as porcine and the porcine kidneys in Figure 2c ,d were incorrectly described as human in the figure legend. The errors have been corrected in the HTML and PDF versions of the article. 
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